Noninvasive Leader Cheetah Medical leads in non-invasive cardiac output and hemodynamic monitoring with FDA clearance and CE marks for the NICOM Reliant and Starling SV systems, offering a safer alternative to invasive Swan-Ganz and an attractive option for centers seeking reduced risk and cost.

Baxter Channel Historical acquisitions by Baxter in 2019 indicate access to established distribution channels that can accelerate penetration in the US and international markets; a joint go-to-market could unlock faster sales growth.

Global Adoption The NICOM and Starling SV systems are used by leading medical centers around the world, presenting opportunities to target large academic medical centers and multisite health systems for broader adoption.

Product Portfolio A cohesive non-invasive monitoring portfolio with NICOM Reliant and Starling SV enables cross-selling across ICU, operating rooms, and cardiology departments within hospital networks.

Strategic Growth Private funding history and strategic acquisitions signal readiness for growth; with current revenue in the lower range and ongoing investment, there is momentum to expand field teams, partnerships, and distributor relationships to scale.